Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology
Disease Category: Acute Myelogenous Leukemia (AML)

Trial Information

Children, Adolescents, and Young Adults with Acute Myeloid Leukemia (AML) Sought for Research Study

UVa Health System, Cancer Center seeks children, adolescents, and young adults aged 1 month through age 29 with De Novo Acute Myeloid Leukemia (AML) for a research study.

Researchers are conducting the study to find out if adding an investigational drug called gemtuzumab (Mylotarg®) to the current standard AML treatment will result in more participants being cured without having bad side effects. In the course of the study, participants will receive Xrays, scans, heart and lung function tests, bone marrow tests, physical exams, blood and urine tests, and spinal taps. Participants will be assigned randomly to either Arm A, which is the current standard therapy for AML, or to Arm B, which is the current standard therapy with gemtuzumab (Mylotarg®). Arm A patients will receive chemotherapy in their vein and in their spinal fluid; Arm B participants will also receive chemotherapy in their vein and their spinal fluid. After 82 days of study treatment, patients may receive more chemotherapy or receive a stem cell transplant at a participating institution based upon results of tests of participants leukemia cells and the response of participants leukemia to the first part of the study treatment.

TreaTreatment on this clinical trial takes approximately 6 to 8 months.

No compensation is available for participation in this study.
Par
Contact Information:
For more information please contact:
Candace Hudspeth, CCRC
(434)982-1091 or ckh3k@virginia.edu
IRB-HSR #13315
Principal Investigator: Kimberly Dunsmore, MD



www.healthsystem.virginia.edu/clinical_trials

Candy Hudspeth CCRC
University of Virginia
School of Medicine
Hematology/Oncology, Pediatrics
Box 800334
Charlottesville, VA 22908
Phone: 434-982-1091
EMail: ckh3k@virginia.edu

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.